These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 51533)

  • 21. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
    Miano L; Manieri C; Paradiso Galatioto G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
    [No Abstract]   [Full Text] [Related]  

  • 22. [Conservative treatment of benign prostatic hypertrophy with gestagen therapy by gestonorone caproate].
    Niijima T; Tanaka H; Takata M
    Hinyokika Kiyo; 1970 Sep; 16(9):508-22. PubMed ID: 4097363
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of meal timing on circadian rhythms in 9 physiologic variables of young healthy but obese women on a calorie restricted diet.
    Apfelbaum M; Reinberg A; Lacatis D
    Int J Chronobiol; 1976; 4(1):29-37. PubMed ID: 1027732
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypogonadotropic hypogonadism with anosmia (Kallmann's syndrome) unresponsive to clomiphene citrate.
    Schroffner WG; Furth ED
    J Clin Endocrinol Metab; 1970 Sep; 31(3):267-70. PubMed ID: 5453324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo-controlled double-blind study in human benign obstructive prostatic hypertrophy with flutamide.
    Bonard M; de Almeida S; von Niederhäusern W
    Eur Urol; 1976; 2(1):24-8. PubMed ID: 61122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease.
    Judd HL; Scully RE; Herbst AL; Yen SS; Ingersol FM; Kliman B
    Am J Obstet Gynecol; 1973 Dec; 117(7):976-82. PubMed ID: 4759835
    [No Abstract]   [Full Text] [Related]  

  • 28. Pituitary-gonadal function in a female hermaphrodite with congenital adrenal hyperplasia.
    Ishida H; Kukutani K; Imao S; Hirose K; Isurugi K
    J Urol; 1976 Jul; 116(1):130-1. PubMed ID: 945358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of candicidin and colestipol on the testes and prostate glands of BIO 87.20 hamsters.
    Wang GM; Schaffner CP
    Invest Urol; 1976 Jul; 14(1):66-71. PubMed ID: 60302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo endocrine studies in adrenal rest tumor of ovary.
    Parker CR; Servy E; McDonough PG; Mahesh VB
    Obstet Gynecol; 1974 Sep; 44(3):327-32. PubMed ID: 4277531
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of urinary 17-OHCS, plasma cortisol and its circadian rhythm during fasting by the obese].
    Linquette M; Fossati P; Decoulx M; Racadot A; Fourlinnie JC; Lefebvre J
    Lille Med; 1968 Jan; 13(1):33-40. PubMed ID: 5744738
    [No Abstract]   [Full Text] [Related]  

  • 32. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 33. Benign prostatic hypertrophy treated with a gestagen. A double-blind clinical trial with randomized allocation.
    Hald T; From A
    Scand J Urol Nephrol; 1972; 6():Suppl 15:157-6. PubMed ID: 4118753
    [No Abstract]   [Full Text] [Related]  

  • 34. [Functional state of the adrenal cortex in cancer and adenoma of the prostate in the process of estrogen therapy].
    Klepikov FA; Genes SG; Popova SS
    Urol Nefrol (Mosk); 1972; 37(6):38-42. PubMed ID: 4124660
    [No Abstract]   [Full Text] [Related]  

  • 35. [Urination disorders, endocrine features and sexual activity in patients with benign prostatic hypertrophy under treatment with mepartricin].
    Scarpa RM; Migliari R; De Lisa A; Campus G; Usai E
    Minerva Urol Nefrol; 1988; 40(2 Suppl):18-20. PubMed ID: 2460939
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report.
    Wolf H; Madsen PO
    J Urol; 1968 Jun; 99(6):780-5. PubMed ID: 4172531
    [No Abstract]   [Full Text] [Related]  

  • 37. [Longitudinal study of urinary excretion of testosterone glucuronate, neuter 17-ketosteroids and 17-ketogenic corticoids in normal subjects].
    Bianchi G; Indiveri F; Rolandi E
    Arch Maragliano Patol Clin; 1970; 26(1):13-20. PubMed ID: 5467883
    [No Abstract]   [Full Text] [Related]  

  • 38. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
    Givens JR; Andersen RN; Wiser WL; Fish SA
    J Clin Endocrinol Metab; 1974 May; 38(5):727-35. PubMed ID: 4823918
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possible effects of lead on various hormonal metabolic pathways].
    Apostoli P; Romeo L; Peroni E; Ferrari S; Aprili F
    G Ital Med Lav; 1988 Jan; 10(1):19-22. PubMed ID: 3151363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.